MAIA Biotechnology Inc. (MAIA)
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University
Stable Commits U.S. $100M to Zenzic Capitals Evergreen Credit Strategy as the Firm Continues its Institutional Expansion
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University
Nightfood Holdings Inc. (OTCQB: NGTF) Builds AI-Driven Automation Tools for Hospitality, Pharmaceutical, Lab and Industrial Spaces
Richtech Robotics Launches Interactive Livestream Featuring AI-Powered Robot ADAM, Enabling Online Users to Engage with ADAM
LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026
Sagtec Global Limited Provides FY2026 Outlook and Highlights Strategic Growth Initiatives
SR BANCORP, INC. ANNOUNCES 20% INCREASE IN QUARTERLY DIVIDEND
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested